NCT07469202 2026-03-13CYTALUX Dose Extension StudyOn Target Laboratories, LLCPhase 4 Not yet recruiting106 enrolled
NCT07453394 2026-03-06QLS5132 Combination Therapy in Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting626 enrolled
NCT07446049 2026-03-03A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low ExpressionConvalife (Shanghai) Co., Ltd.Phase 2 Not yet recruiting180 enrolled
NCT07420010 2026-02-19An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.Zhejiang UniversityPhase EARLY_PHASE1 Not yet recruiting24 enrolled
NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled
NCT06754761 2025-01-01Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of CeralasertibAstraZenecaPhase 1 Not yet recruiting8 enrolled